Antimicrobial resistance genes in bioaerosols in Canadian arctic, rural, and urban environments: sources, profiles, transport and fate
加拿大北极、农村和城市环境中生物气溶胶中的抗菌素耐药性基因:来源、概况、运输和归宿
基本信息
- 批准号:539024-2019
- 负责人:
- 金额:$ 72.85万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Frontiers - Antimicrobial Resistance
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Humans, through many of their activities, have been selecting and amplifying bacteria that carry genes for antibiotic resistance. Bioaerosols are understudied as reservoirs and propagation sources of antibiotic resistant microbes. Bioaerosols are defined by airborne particles of biological origin. They are found everywhere, emitted from natural and man-made sources such as agriculture, water, plants and industrial activities. Air can lead to long distance transmission of biological agents and potential impact of human activities on spreading of antimicrobial resistance through the air must be better understood to fill appropriate risk and prevention models. Various sampling strategies will be deployed across the country to survey and map Canada's air contamination in various sites (urban, rural, arctic) thanks to an international team. Long distance transport and high atmosphere antimicrobial resistance content will be addressed. The samples collected will be used to evaluate health risks and gene transfer potential. In Canada, we have the opportunity to study ARG dissemination on an East-West axis, a North-South axis, as well as on a vertical axis (high troposphere and clouds), including four out of five Koppen climate types (dry, temperate, continental, polar). This project will thus address long-distance transport of ARG through sampling in the Far North of Canada and in the high atmosphere, overseas and through diverses urban and rural activities. The proposed program will fill huge gaps in the understanding of the spreading and exposure of antimicrobial resistance through bioaerosols in Canada. An important outcome will be to add bio aerosols in risk assessment models and develop projects to determine appropriate mitigation and attenuation measure in key areas. This program will generate a cohort of HQP with pioneer experience in ARG and bioaerosol, a unique profile of great value for Canada. This research program has the power to transform, to change paradigms by including the "air" in ARG exposure and risk models andprediction, to develop new research disciplines, to have spin-offs in Canada and internationally by exporting expertise to other man-made and natural activities and describe their ARG contribution.
通过许多活动,人类一直在选择和放大携带抗生素耐药性基因的细菌。生物气溶胶作为耐抗生素微生物的储存库和繁殖源的研究还不够深入。生物气溶胶是由生物来源的空气中的颗粒定义的。它们随处可见,来自自然和人为来源,如农业、水、植物和工业活动。空气可导致生物制剂的长距离传播,必须更好地了解人类活动对通过空气传播抗菌素耐药性的潜在影响,以填补适当的风险和预防模型。多亏了一个国际团队,加拿大将在全国范围内部署各种采样策略,以调查和绘制加拿大不同地点(城市、农村、北极)的空气污染情况。将解决长途运输和高大气抗菌素含量问题。收集的样本将用于评估健康风险和基因转移潜力。在加拿大,我们有机会研究ARG在东西轴、南北轴以及垂直轴(高对流层和云层)上的传播,包括五分之四的高朋气候类型(干燥、温带、大陆性和极地)。因此,该项目将通过在加拿大最北部和高大气、海外以及通过城乡活动的不同途径进行采样,解决ARG的长途运输问题。拟议的计划将填补在加拿大通过生物气溶胶传播和暴露抗菌素耐药性方面的巨大空白。一项重要成果将是在风险评估模型中加入生物气溶胶,并制定项目以确定关键地区的适当缓解和衰减措施。该计划将产生一批在ARG和生物气溶胶方面具有先锋经验的HQP,这是对加拿大具有重要价值的独特概况。这一研究计划有能力通过将“空气”纳入ARG暴露和风险模型和预测来改变范式,开发新的研究学科,通过向其他人造和自然活动输出专业知识在加拿大和国际上产生衍生产品,并描述他们对ARG的贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Duchaine, CarolineC其他文献
Duchaine, CarolineC的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Naringin通过改善Leptin Resistance调节肠上皮AQP3重建糖脂代谢平衡的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
- 批准号:82372275
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
- 批准号:82371873
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
- 批准号:82372203
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
SUCLA2失调控介导的琥珀酸代谢异常促进巨噬细胞炎性活化及肥胖发生
- 批准号:32000525
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
PRMT1-meFOXO1通路在低温常压等离子体诱导的三阴型乳腺癌细胞铁死亡中的作用机制研究
- 批准号:31900528
- 批准年份:2019
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
去唾液酸糖蛋白受体1(ASGR1)调控脂质转运的分子机制及其在非酒精性脂肪肝炎中的作用研究
- 批准号:31900539
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
ISLR参与肥胖小鼠胰岛素抵抗的机制研究
- 批准号:31970712
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
RND驱动重金属外排泵介导的细菌性果斑病菌抗铜机制及其调控机理研究
- 批准号:31560498
- 批准年份:2015
- 资助金额:39.0 万元
- 项目类别:地区科学基金项目
地塞米松诱导的人卵巢癌对化疗药物耐受及其机制的研究
- 批准号:81172471
- 批准年份:2011
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Discovery and characterization of overlooked antimicrobial resistance genes and mechanisms
被忽视的抗菌素耐药基因和机制的发现和表征
- 批准号:
490581 - 财政年份:2023
- 资助金额:
$ 72.85万 - 项目类别:
Operating Grants
Variability in responses of antimicrobial resistance genes to lifting COVID-19-related measures among different population groups : A comparative study of the general public, university campus community, and marginalized groups
不同人群中抗菌素耐药性基因对取消 COVID-19 相关措施的反应差异:对公众、大学校园社区和边缘群体的比较研究
- 批准号:
495187 - 财政年份:2023
- 资助金额:
$ 72.85万 - 项目类别:
Fate of antimicrobial resistance genes in wastewater treatment processes focusing on their carrier bacteria and viruses.
废水处理过程中抗菌素耐药性基因的命运主要集中在其载体细菌和病毒上。
- 批准号:
23H01535 - 财政年份:2023
- 资助金额:
$ 72.85万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The effects of environmental metals on the spread of antimicrobial resistance genes in the stickleback skin microbiome
环境金属对刺鱼皮肤微生物群中抗菌素耐药性基因传播的影响
- 批准号:
2846505 - 财政年份:2023
- 资助金额:
$ 72.85万 - 项目类别:
Studentship
Using strain history to improve prediction of the evolution of antimicrobial resistance in Acinetobacter baumannii
利用菌株历史改进对鲍曼不动杆菌抗菌药物耐药性演变的预测
- 批准号:
10677362 - 财政年份:2023
- 资助金额:
$ 72.85万 - 项目类别:
Silencing and reactivation of antimicrobial resistance genes in Enterobacteriaceae
肠杆菌科抗菌药物耐药基因的沉默和重新激活
- 批准号:
2745958 - 财政年份:2022
- 资助金额:
$ 72.85万 - 项目类别:
Studentship
Transfer and stability of antimicrobial resistance (AMR) genes in Methicillin-Resistant Staphylococcus aureus (MRSA)
耐甲氧西林金黄色葡萄球菌 (MRSA) 中抗菌素耐药性 (AMR) 基因的转移和稳定性
- 批准号:
2734850 - 财政年份:2022
- 资助金额:
$ 72.85万 - 项目类别:
Studentship
Characterizing novel Beta-lactamases from metagenomic samples: insights into the evolution of antimicrobial resistance from the environment towards human-associated pathogens
从宏基因组样本中表征新型 β-内酰胺酶:深入了解从环境到人类相关病原体的抗菌药物耐药性的演变
- 批准号:
10450287 - 财政年份:2022
- 资助金额:
$ 72.85万 - 项目类别:
Development of a broad spectrum antimicrobial to combat chronic lung infection
开发广谱抗菌药物来对抗慢性肺部感染
- 批准号:
10480299 - 财政年份:2022
- 资助金额:
$ 72.85万 - 项目类别:
A novel antimicrobial resistance mechanism for Borrelia burgdorferi
伯氏疏螺旋体的新型抗菌药物耐药机制
- 批准号:
10425475 - 财政年份:2022
- 资助金额:
$ 72.85万 - 项目类别: